ITGR logo

INTEGER HOLDINGS CORP

ITGRNYSE
๐Ÿ† #1402 by market capEarnings Oct 21US Equity
$125.29โ–ฒ $0.25 (+0.20%)
Live
1hโ–ฒ 0.0%
24hโ–ฒ 0.2%
7dโ–ฒ 0.2%
14dโ–ฒ 26.0%
30dโ–ฒ 30.0%
1yโ–ฒ 16.8%
๐ŸฆMarket Cap
$4.25B
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+2.7%
Slowing
๐Ÿ“ŠGross Margin
26.1%
Moderate
๐Ÿ’ตFCF Margin
6.1%
Moderate
โš–๏ธP/S Ratio
2.3x
Cheap
Otter Score
56
Weak

Trading Snapshot

Day Range
$124.53 โ€“ $126.41
52-Week Range
$62.00 โ€“ $126.14
Volume
$3.82B
Avg Volume
$3.02B
Shares Outstanding
34.0M
Next Earnings
Sep 14, 2026

Fundamentals Snapshot

Annual Revenue
$1.85B
Last Q Revenue
$464M
P/E Ratio
33.1
P/S Ratio
2.3x
EPS (TTM)
$3.67
Dividend Yield
โ€”

Why Investors Own ITGR

  • โœ“High-growth profile โ€” revenue up +36.4% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 26% gross margin and 7% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$1.85Bโ–ฒ +37.0% YoY
Gross Margin (TTM)
25.7%โ–ผ โˆ’0.3% YoY
Operating Income (TTM)
$401Mโ–ฒ +37.0% YoY
Free Cash Flow (TTM)
$131Mโ–ฒ +37.0% YoY

About INTEGER HOLDINGS CORP

Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
56/100

Analyst Ratings

โ“˜
Consensus
Buy
17 analysts
Strong Buy3
Buy8
Hold6
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates